Compact CRISPR System Unlocks Targeted in-Body Gene Editing, with up to 90% Efficiency

Compact CRISPR system unlocks targeted in-body gene editing, with up to 90% efficiency

A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human body—a key step toward broader clinical use. Researchers identified a naturally occurring enzyme, Al3Cas12f, that is small enough to fit into adeno-associated virus vectors, a leading targeted delivery method for gene therapies. They then engineered an enhanced version that dramatically improved gene-editing performance in h…

Tiny new CRISPR molecule could revolutionize therapeutic genome editing

A groundbreaking advance in gene editing technology has emerged from the University of Texas at Austin, as researchers have engineered a novel CRISPR-based molecular tool that holds promise for direct therapeutic gene editing inside the human body. A collaborative effort involving scientists funded by the National Institutes of Health (NIH) and the biotech company Metagenomi Therapeutics, this innovation overcomes a significant barrier: the size…

NIH Breakthrough: Miniaturized CRISPR Enhances Gene Editing Precision

Archyde NIH-funded researchers have engineered a miniaturized CRISPR-Cas system, overcoming the primary hurdle of delivery size. By shrinking the molecular machinery, scientists can now utilize standard viral vectors to transport gene-editing ... Read More The post NIH Breakthrough: Miniaturized CRISPR Enhances Gene Editing Precision appeared first on Archyde.